Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: David Gogishvili Clear advanced filters
  • CD229 is expressed on the surface of multiple myeloma cells, as well as B and T lymphocytes. Here, the authors engineer CD229-specific CAR T cells and, using patient samples and mouse models, show that treatment with these cells reduces tumour burden and results in limited targeting of T cells.

    • Sabarinath V. Radhakrishnan
    • Tim Luetkens
    • Djordje Atanackovic
    ResearchOpen Access
    Nature Communications
    Volume: 11, P: 1-9
  • Results from EMPOWER-Lung 3 demonstrate increased overall survival with cemiplimab plus platinum-doublet chemotherapy compared to cemiplimab as first-line treatment in patients with advanced non-small cell lung cancer, irrespective of PD-L1 expression.

    • Miranda Gogishvili
    • Tamar Melkadze
    • Petra Rietschel
    ResearchOpen Access
    Nature Medicine
    Volume: 28, P: 2374-2380
  • Sustainability has been added as a ‘pillar’ of the Olympic movement, but this analysis examines each Summer and Winter Games since 1992 to find that the performance of host cities across a range of indicators has been declining over time.

    • Martin Müller
    • Sven Daniel Wolfe
    • Annick Leick
    Research
    Nature Sustainability
    Volume: 4, P: 340-348